With multiple, complex chromatographic purification, buffer exchange, and viral inactivation steps, downstream processing of monoclonal antibodies (mAbs) remains the major bottleneck in ...
Optimizing the downstream process for adeno-associated virus (AAV) production with consistent quality depends on the ability to characterize critical quality attributes affecting the final product’s ...
In this webcast, Catalent will share a case study of a monoclonal antibody (mAb) from clinical to commercial phase under a highly compressed timeline. Process characterization and validation is an ...
With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...
Drug firms looking to ramp-up production with continuous processes must think beyond the reactor and ensure the technologies used downstream can also manage sustained 24/7 manufacturing. Continuous ...
Acquisition expands Siemens' offering in PCB design for the SMB market and enables greater process coverage, from design to manufacturing preparation PLANO, Texas, April 8, 2025 /PRNewswire/ -- ...
Ingelheim,Germany, 10 September 2012 –Boehringer Ingelheim has developed and now implemented a flexible set-up and operational approach for disposable technologies within its global biopharmaceutical ...
Drug development and manufacturing have undergone a seismic shift in the last two decades, 1 from blockbuster small molecules to highly personalized biologics 2 and cell and gene therapies. Because ...
Gttingen, Germany - (NewMediaWire) - May 14, 2024 - The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and ...
The global PAEK-based solutions provider announced – as part of its 2015 financial results – that it will build a new PEEK composite facility for unidirectional (UD) tape and add new manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results